Treatment of xerostomia. A review;Tratamiento de la xerostomía. Una revisión

Medicina Oral

Volumn 6, Issue 1, 2001, Pages 7-18

  Guijarro, B G ^a   Lopez A F S ^a   Hernandez G V ^a  

^a NONE   (Spain)

Author keywords

Treatment; Xerostomia

Indexed keywords

ANETHOLE TRITHIONE; BETHANECHOL; BROMHEXINE; BUCOHIDRAT; LUBORANT; MOUTH KOTE; PILOCARPINE; PYRIDOSTIGMINE; SALIVA SUBSTITUTE; UNCLASSIFIED DRUG; UNIMIST;

HUMAN; MASTICATION; PROPHYLAXIS; REVIEW; SALIMENT; SALIVA; SALIVATION; XEROSTOMIA;

HUMANS; XEROSTOMIA;

EID: 4143052795     PISSN: 11372834     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (70)

1. La xerostomia: Fisiopatología, etiopatogenia, cuadro clínico, diagnóstico y tratamiento
2. Desórdenes del flujo salival: Hiposecreción e hipersecrececión salival
3. Xerostomia. Part I: Relationship to other oral symptoms and salivary gland hypofunction
4. Recognition and treatment of salivary induced conditions
5. Whole saliva secretion by old and young adults
6. Unstimulated and stimulated parotid flow rates in individuals of different ages
7. Criterios terapéuticos ante una xerostomia
8. Salivary gland dysfunction: Causes, symptoms, treatment
9. Xerostomia - Diagnosis and treatment
10. Oral side-effects of the most frequently prescribed drugs
11. Xerostomia: Diagnosis and treatment planning considerations
12. Narcotics and teeth
13. Salivary secretion and dental caries experienced in drug addicts
14. Managing the oral manifestations of cancer therapy, part 1: Head-and-neck radiation therapy
15. The head and neck radiotherapy patient: Part 1 oral manifestations of radiation therapy
16. Parotid saliva composition during and after irradiation of head and neck cancer
17. The salivary gland component of Sjögren's syndrome: An evaluation of diagnostic methods
18. Primary Sjögren's syndrome (pSS): Subjective symptoms and salivary findings
19. Pilocarpine for the treatment of xerostomia associated with salivary gland dysfunction
20. Mucin-containing lozenges in the treatment of intraoral problems associated with Sjogren's syndrome
21. El uso de reservorios de saliva en la terapeútica de la xerostomia
22. The establishment of a xerostomia clinic: A prospective study
23. A hydrophillic chewing gum for xerostomic patients
24. Xerostomia. Diagnosis and treatment
25. Pilocarpine oral solution
26. Effects of pilocarpine on salivary flow in patients with Sjögren's syndrome
27. Effectiveness of pilocarpine in postradiation xerostomia
28. The use of pilocarpine in postradiation xerostomia
29. Synergistic effect of sialogogues in management of xerostomia after radiation therapy
30. The head and neck radiotherapy patient: Part 2. Management of oral complications
31. Pilocarpine used to stimulate normal saliva production
32. Pilocarpine treatment of salivary gland hypofunction and dry mouth (xerostomia)
33. Scientists find remedy for patients suffering from post-irradiation xerostomia
34. Use of pilocarpine during head and neck radiation therapy to reduce xerostomia and salivary dysfunction
35. Synergistic effect of sialogogues in management of xerostomia after radiation therapy
36. Effect of Sialor in tratment of xerostomia in Sjögren's syndrome
37. Use of bethanechol chloride with phenothiazines: A case report
38. A clinical trial of bethanechol in patients with xerostomia after radiation therapy
39. Sjögren's syndrome treated with bromexine: A reassessment
40. Xerostomia: Diagnosis and treatment
41. Disppyramide-pyridostigmine: Report of a beneficial drug interaction
42. A double-blind cross-over trial of a mucin-containing artificial saliva
43. An audit of oral and dental health regimens practised in the management of oropharyngeal cancer
44. Effect of Saliment® on parotid salivary gland secretion and on xerostomia caused by Sjögren syndrome
45. Manifestations and treatment of xerostomia and associated oral effects secondary to head and neck radiation therapy
46. The effect of mucin-containing artificial saliva in severe xerostomia
47. The preparation of an autologous saliva for use with patients undergoing therapeutic radiation for head and neck cancer
48. The use of milk as a saliva substitute
49. Use of an electronic stimulator for treatment of dry mouth
50. Electrical stimulation of salivary flow in patients with Sjögren syndrome
51. Construction of an artificial saliva reservoir in an existing maxillary denture
52. Can α-tocoferol and β-caroteno supplementation reduce adverse radiation effects on salivary glands
53. Acupuncture treatment of patients with radiation-induced xerostomia
54. The effect of acupuncture on salivary flow rates in patients with xerostomia
55. An evaluation of a dentifrice containing salivary peroxidase elements for the control of gingival disease in patients with irradiated head and neck cancer
56. Management of patients with xerostomia
57. Reconocimiento y tratamiento de las afectaciones de origen salival
58. Prevention and treatment of the orofacial complications of radiotherapy
59. Sjögren's syndrome: Oral and dental considerations
60. In vivo study on the prevention of radiation caries
61. Compliance with fluoride gel use in irradiated patients
62. Betaine-containing toothpaste relieves subjective symptoms of dry mouth
63. The efficacy of chlorhexidine gel in reduction of Streptococcus mutans and Lactobacillus species in patients treated with radiation therapy
64. Effect of chlorhexidine gel treatment on the prevalence of mutans streptococci and lactobacilli in patients with impaired salivary secretion rate
65. Local radiation and systemic chemotherapy: Preventing and managing the oral complications
66. Management of oral complications associated with cancer therapy in pediatric patients
67. Oral health care for the cancer patient
68. HIV-associated salivary gland disease: A review
69. Management of oral health in persons with HIV infection